Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine

This is the first study examining serotype-specific IgG responses following immunization with the polysaccharide vaccine Pneumovax® in infants aged 12 months in the absence of prior pneumococcal conjugate vaccine priming.